Single Nucleus RNA Sequencing (snRNA-seq) is a powerful transcriptomics method that enables gene expression profiling at the resolution of individual cell nuclei. This technique has become essential for studying human brain tissue, particularly in neurodegenerative disease research where fresh tissue is often unavailable[^1].
snRNA-seq involves isolating intact nuclei from tissues, followed by RNA extraction and sequencing:
- Tissue preparation: Brain tissue is gently dissociated to release nuclei
- Nucleus isolation: Nuclei are purified using density gradient centrifugation or fluorescence-activated nuclear sorting (FANS)
- RNA extraction: Total RNA is extracted from purified nuclei
- Library preparation: cDNA libraries are generated using specialized protocols
- Sequencing: Libraries are sequenced to obtain transcriptomic data
snRNA-seq offers several advantages over other single-cell approaches:
- Frozen tissue compatibility: Works with archived and frozen brain samples
- Large-scale studies: Enables analysis of hundreds of individuals
- Cell type resolution: Captures diverse neuronal and glial cell types
- Integration with genetics: Can be combined with genotype data for eQTL analysis
snRNA-seq has revealed distinct transcriptional programs in different brain cell types[^2]:
- Neurons: Show reduced synaptic gene expression in AD
- Microglia: Exhibit disease-associated activation states
- Astrocytes: Display altered metabolic and inflammatory signatures
- Oligodendrocytes: Show impaired myelination-related gene expression
The technique enables identification of:
- Cell-type specific vulnerability: Which cell types are most affected in AD
- Novel cell states: Previously unrecognized cellular phenotypes
- Trajectory analysis: How gene expression changes during disease progression
Integration with genotype data allows[^3]:
- eQTL analysis: Identifying genetic variants affecting gene expression
- Cell-type specificity: Determining which cell types show genetic effects
- AD risk variant mechanisms: Understanding how GWAS variants affect biology
The Seattle-Alzheimer's Disease Brain Cell Atlas (SEA-AD) has used snRNA-seq to:
- Survey cells across the entire adult human brain[^4]
- Generate transcriptomes from neocortex of hundreds of individuals[^5]
- Identify microglial states specific to AD[^6]
- Map the effects of genetic variants on RNA expression in brain cells
snRNA-seq data has contributed to:
- Cell type taxonomies: Comprehensive classification of brain cell types
- Marker gene identification: Genes specific to each cell type
- Cellular neighborhoods: Understanding spatial organization of cell types
| Feature |
scRNA-seq |
snRNA-seq |
| Sample requirement |
Fresh tissue |
Frozen tissue acceptable |
| Cell types captured |
May miss large cells |
Captures all sizes |
| Nucleus purity |
Not applicable |
Critical |
| Gene detection |
Full transcriptome |
Reduced for some genes |
snRNA-seq complements spatial transcriptomics by providing:
- Higher cellular resolution
- Deeper gene detection
- Integration with spatial context
¶ Challenges and Limitations
- Nuclear RNA: Contains pre-mRNA and non-polyadenylated transcripts
- Gene coverage: May miss some cytoplasmic transcripts
- Cellular dissociation: Technical challenges with some brain regions
- Batch effects: Large-scale studies require careful normalization
- Single-nucleus RNA sequencing reveals cell type-specific responses in AD brain
- Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease
- Genetic variant effects on gene expression in the human brain
- High-throughput single-nucleus RNA sequencing of the adult human brain
- Single-nucleus RNA sequencing of neocortex from 424 individuals
- Microglial states in Alzheimer's disease brain identified by snRNA-seq